Odanacatib Inhibits Resistin-induced Hypertrophic H9c2 Cardiomyoblast Cells Through LKB1/AMPK Pathway
ABSTRACT Odanacatib (ODN) is a selective inhibitor of cathepsin K. The cysteine protease cathepsin K has been implicated in cardiac hypertrophy. Resistine is an adipokine which is identified to promote cardiac hypertrophy. Here, we hypothesize that ODN mitigates resistin-induced myocyte hypertrophy....
Main Authors: | Xian Zheng, Huzi Liu, Guanchang Cheng, Jianwei Luo, Qunhui Ye, Yongzhi Deng, Lin Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto de Tecnologia do Paraná (Tecpar)
2017-08-01
|
Series: | Brazilian Archives of Biology and Technology |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132017000100309&lng=en&tlng=en |
Similar Items
-
PKA Activates AMPK Through LKB1 Signaling in Follicular Thyroid Cancer
by: Suresh Kari, et al.
Published: (2019-11-01) -
Role of oxidative modifications of LKB1 in promoting myocardial hypertrophy
by: Calamaras, Timothy Dean
Published: (2016) -
Potential role of odanacatib in the treatment of osteoporosis
by: Ng KW
Published: (2012-07-01) -
PIM kinases inhibit AMPK activation and promote tumorigenicity by phosphorylating LKB1
by: Kwan Long Mung, et al.
Published: (2021-06-01) -
LKB1-AMPK-SIK2-CRTC2 Pathway in Beta Cells
by: Fu, Accalia
Published: (2013)